HG-1126

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameHG-1126

Drug Alias NameCRADD modulator (Human Genome Sciences)MGC9163 modulator (Human Genome Sciences)RAIDD modulator (Human Genome Sciences)RIP-associated ICH1/CED3-homologous protein with death domain modulator (Human Genome Sciences)CASP2 and RIPK1 domain containing adaptor with death domain modulator (Human Genome Sciences) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCaspase-2 modulatorsReceptor-interacting serine/threonine-protein kinase 1 modulators

TargetsCaspase-2Receptor-interacting serine/threonine-protein kinase 1

Therapy Area/IndicationsImmune System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHuman Genome Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHuman Genome Sciences Inc

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A